Yes, the company's confident that the Shareholder Nominees will stay invalidated, but they were also confident they would prevail in previous legal matters and that was not the case. All I want is a fair Proxy Contest. I will live with the result and support Leronlimab's development no matter who is in charge. That said, as I have said before, my Proxy will go to the Shareholder Nominees.
News 
Market Data 
Discover 
